Oxford Nanopore has a broad patent portfolio, through
in-house development and licensing agreements with third parties. The
Company is developing a platform technology that may be adapted with a variety
of nanopore sensors for the analysis of different molecules. The IP
portfolio reflects the broad range of expertise and active R&D projects
that are in progress at Oxford Nanopore and supported research within the
laboratories of our academic
collaborators. These projects include the development of nanopore DNA
sequencing technology (exonuclease and strand sequencing), protein analysis,
and the development of solid state nanopores.
The Company was founded on science from the laboratory of Professor Hagan
Bayley of the University of Oxford and maintains a broad range of IP licenses
with this institution. In 2008 a series of agreements were announced to
exclusively develop and commercialise discoveries from nanopore research laboratories
at Harvard (including discoveries at the US National Institute
of Standards and Technology, NIST) and University
of California Santa Cruz. These extended a portfolio that also
includes Texas A&M and the University of Massachusetts Medical School.
The following themes are included in
Oxford Nanopore's patent portfolio: